Long‐term clinical profile of children with the low‐penetrance R92Q mutation of the TNFRSF1A gene
Open Access
- 10 January 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (4), 1141-1150
- https://doi.org/10.1002/art.30237
Abstract
Objective To analyze the long‐term impact of the R92Q mutation of TNFRSF1A in children with periodic fever, in comparison with children with tumor necrosis factor receptor–associated periodic syndrome (TRAPS) with TNFRSF1A structural mutations and children with periodic fever of unknown origin fulfilling the criteria for periodic fever, aphthosis, pharyngitis, and adenitis syndrome (PFAPA). Methods The extracellular region of TNFRSF1A was analyzed in 720 consecutive children with periodic fever, using denaturing high‐performance liquid chromatography and DNA sequencing. Followup data on 11 pediatric patients with TNFRSF1A structural mutations (cysteine or T50M), 23 pediatric patients with an R92Q substitution, and 64 pediatric patients with PFAPA were collected during routine clinic visits. The 50‐item Child Health Questionnaire was used to assess health‐related quality of life (HRQOL). Results The frequency of typical TRAPS‐related clinical manifestations was significantly lower and the impact of the disease on HRQOL was significantly reduced in patients with the R92Q mutation compared with TRAPS patients carrying structural mutations of TNFRSF1A. Followup data on 11 TRAPS patients with TNFRSF1A structural mutations (mean followup 7.9 years), 16 patients with theR92Q substitution (mean followup 7.3 years), and 64 patients with PFAPA (mean followup 5.2 years) were available. Patients with R92Q mutations and patients with PFAPA displayed a higher rate of self‐resolution or amelioration of the fever episodes than did TRAPS patients with structural mutations. Conclusion Although some cases may progress to a more chronic disease course, the majority of children with an R92Q mutation of the TNFRSFA1 gene show a milder disease course than that in children with TNFRSFA1 structural mutations and have a high rate of spontaneous resolution and amelioration of the recurrent fever episodes.Keywords
This publication has 30 references indexed in Scilit:
- Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndromeProceedings of the National Academy of Sciences of the United States of America, 2010
- Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristicsRheumatology, 2009
- Late‐onset tumor necrosis factor receptor–associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutationArthritis & Rheumatism, 2007
- The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosisAnnals Of The Rheumatic Diseases, 2007
- The TNFRSF1A R92Q mutation is frequent in rheumatoid arthritis but shows no evidence for association or linkage with the diseaseAnnals Of The Rheumatic Diseases, 2007
- Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A geneAnnals Of The Rheumatic Diseases, 2006
- Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)Blood, 2006
- MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent feverEuropean Journal of Human Genetics, 2004
- Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: A low‐penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versaArthritis & Rheumatism, 2004
- Syndrome of periodic fever, pharyngitis, and aphthous stomatitisThe Journal of Pediatrics, 1987